Management of sexually transmitted infections in HIV positive individuals

Current Opinion in Infectious Diseases

Volumn 18, Issue 1, 2005, Pages 43-47

  Gilleece, Yvonne ^a   Sullivan, Ann ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; BENZATHINE PENICILLIN; ERYTHROMYCIN; IMIQUIMOD; PEGINTERFERON; RIBAVIRIN; TETRACYCLINE; TRIFLURIDINE; VALACICLOVIR;

CONDOM; ENZYME IMMUNOASSAY; EPIDEMIC; HEALTH CARE SYSTEM; HEPATITIS C; HERPES SIMPLEX VIRUS 2; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LEGAL ASPECT; LYMPHOGRANULOMA VENEREUM; REVIEW; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; SYPHILIS SEROLOGY; UNITED KINGDOM; VIRUS TRANSMISSION; WART VIRUS; AIDS RELATED COMPLEX; DISEASE TRANSMISSION; HERPES SIMPLEX; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; RISK FACTOR; SEXUAL BEHAVIOR;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; HEPATITIS C; HERPES SIMPLEX; HIV INFECTIONS; HUMANS; LYMPHOGRANULOMA VENEREUM; RISK FACTORS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; SYPHILIS;

EID: 17544383923     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200502000-00008     Document Type: Review

References (42)

1. Stamm WE, Handsfield HH, Rompalo AM, et al. The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA 1988; 260:1429-1433.
2. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in Tanzania: randomised controlled trial. Lancet 1995; 346:630-636.
3. Wawer JN, Sewankambo NK, Serwadda D, et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Lancet 1999; 353:525-535.
4. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Inf 1999; 75:3-17.
5. A General Medical Council publication regarding Guidance on good practice, under core document entitled Serious Communicable Disease, paragraphs 18-21. Online publication available at http://www.gmc-uk.org/globa_sections/ search_frameset.htm. [Accessed November 2004].
6. Campsmith ML, Begley EB, Nakamura GV. Div of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, CDC. High-risk sexual behaviour by HIV-positive men who have sex with men: 16 sites, United States, 2000-2002. MMWR 2004; 53:891-894.
7. Stolte IG, de Wit JB, van Eeden AC, et a. Perceived viral load, but not actual HIV-1-RNA, is associated with sexual risk behaviour among HIV-infected homosexual men. AIDS 2004; 18(14):1943-1949. This study suggested that a simple intervention such as discussing HIV viral load result with patient may alter sexual risk behaviour.
8. Wilson TE, Gore ME, Greenblatt R, et al. Changes in sexual behaviour among HIV-infected women after initiation of HAART. AIDS 2004; 18:1943-1949.
9. Glass T, Young J, Vernazza P, et al. Is unsafe sexual behaviour increasing among HIV-infected individuals? 2004; 18:1707-1714. This study examines sexual behaviour in the Swiss cohort of HIV positive patients.
10. Trends in primary and secondary syphilis and HIV infections in men who have sex with men: San Francisco and Los Angeles, California, 1998-2002. MMWR 2004; 53:575-578.
11. Trends in infectious syphilis; update on national data to 2003 and current epidemiological data from the London outbreak. CDR Weekly 2004 14; 31:1-4.
12. Rolfs RT, Joesef MR, Hendershot EF, et al. A randomised trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337(5):307-314.
13. Goh B. National Guidelines on the Management of Early Syphilis. Clinical Effectiveness Guidelines for the British Association of Sexual Health and HIV available online at: http://www.bashh.org/guidelines/2002/ early$final0502.pdf, p. 7-8. [Accessed November 2004].
14. Gotz H, Nieuwenhuis R, Ossewaarde T, et al. Preliminary report of an outbreak of lymphogranuloma venereum in homosexual men in the Netherlands, with implications for other countries in western Europe. Eurosurveillance Weekly 2004; 8:1. This paper captures the key elements at the start of the European outbreak of LGV and advises increased surveillance.
15. Vandenbruaene M. Outbreak of lymphogranuloma venereum in Antwerp and Rotterdam. Epidemiologisch Bulletin van de Vlaamse Gemeenschap 2004; 47(1):4-6.
16. Berglund T, Herrmann B. Outbreak of lymphogranuloma venereum (LGV) in Europe. EPI-aktuellt 2004; 3:2-3.
17. A document released by the Department of Infectious Diseases, Institut de Veille Sanitaire. The emergence of rectal lymphogranuloma venereum in France: case estimates to 1 September 2004. Online serial, http://www.invs.sante.fr/ display/?doc=presse/2004/le_point_sur/lgv_091104/index.html [Accessed November 2004].
18. LGV in men who have sex with men. CDR weekly 2004; 14:3. This provides an informative account of an LGV outbreak in the United Kingdom with practical advice on the diagnosis and reporting of LGV.
19. Faro S. Lymphogranuloma venereum, chancroid and granuloma inguinale. Obstet Gynecol Clin North Am 1989; 16:517-529.
20. Goens JL, Schwartz RA, DeWolf K. Mucocutaneous manifestation of chancroid, lymphogranuloma venereum, and granuloma inguinale. Am Fam Physician 1994; 49:415-425.
21. Hirschberg SM, Horton CE. Radical perineal resection for far advanced lymphogranuloma venereum. Plast Reconstr Surg 1973; 51:217-219.
22. Browne R, Asboe D, Gilleece Y, et al. Increased numbers of acute hepatitis C infections in HIV positive homosexual men; is sexual transmission feeding the increase? Sex Transm Infect 2004; 80:326-327. This study reflects the growing trend of sexual transmission of hepatitis C among MSM in urban HIV clinics.
23. Ghosn J, Pierre-Francois S, Thibault V, et al. Acute hepatitis C in HIV infected men who have sex with men. HIV Med 2004; 5:303-306.
24. de los Angeles Pando M, Biglione MM, Toscano MF, et al. Human immunodeficiency virus type 1 and other viral co-infections among young heterosexual man and women in Argentina. Am J Trop Med Hyg 2004; 71:153-159.
25. Nelson M, Matthews G, Brook G, Main J. British HIV Association (BHIVA) guidelines: coinfection with HIV and chronic hepatitis C virus. HIV Med 2003; 4(Suppl 1):52-62.
26. Gilleece Y, Nelson M, Asboe D, et al. To evaluate changes in incidence and treatment of acute hepatitis C infection [abstract]. In: Program and Abstracts of the XV International AIDS Conference, July 2004. Bangkok.
27. Jaeckel E, Cornberg M, Wedemayer H, et al. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 2001; 345:1452-1457.
28. Bagdades EK, Pillay D, Squire SB, et al. Relationship between herpes simplex virus ulceration and CD4+ lymphocyte counts in patients with HIV infection. AIDS 1992; 6:1317-1320.
29. Wright PW, Hoesley CJ, Squires KE, et al. A prospective study of genital herpes simplex virus type 2 infection in human immunodeficiency virus type 1 (HIV-1) seropositive women: correlations with CD4 cell count and plasma HIV-1 RNA level. Clin Infect Dis 2003; 36:207-211.
30. Schaker T, Zeh J, Hu H, et al. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J Infect Dis 2002; 186:1718-1725.
31. Posovad CM, Wald A, Kuntz S, et al. Frequent reactivation of herpes simplex virus among HIV-1 infected patients treated with highly active antiretroviral therapy. J Infect Dis 2004; 190:693-696. The authors provide important data on HSV-2 viral shedding in the post-HAART era which suggests suppressive aciclovir treatment is still necessary in patients with immune reconstitution.
32. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2 seropositive persons: a meta-analysis. J Infect Dis 2002; 185:45-52.
33. Corey L, Wald A, Patel R, et al. Once daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004; 350:11-20. This was a large trial in heterosexual couples showing significant reductions in HSV-2 transmission using suppressive valaciclovir.
34. Barton S, Brown D, Cowan F, et al. National Guidelines on the Management of genital herpes simplex. Clinical Effectiveness Guidelines for the British Society of Sexual Health and HIV, available online at: http://www.bashh.org/ guidelines/2002/hsv_0601.pdf, p.1 7, Fig. 1. [Accessed November 2004].
35. Melbye M, Smith E, Wolfhart J, et al. Anal and cervical abnormality in women: prediction by human papillomavirus tests. Int J Cancer 1996; 68:559-564.
36. Wright T, Moscarelli R, Dole P, et al. Significance of mild cytologic atypia in women infected with human immunodeficiency virus. Obstet Gynecol 1996; 87:515-519.
37. Fruchter R, Maiman M, Sedlis A, et al. Multiple recurrences of cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus. Obstet Gynecol 1996; 87:338-344.
38. Hawes SE, Critchlow CW, Faye N, et al. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections. J Infect Dis 2003; 188:555-563.
39. Minkoff H, Feldman JG, Strickler HD, et al. Relationship between smoking and HPV infections in HIV-infected and uninfected females. J Infect Dis 2004; 189:1821-1828.
40. Piketty C, Darragh TM, Da Costa M, et al. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV infected persons in the absence of anal intercourse. Ann Intern Med 2004; 138:453-459. This presents concise clear data revealing that there may not always be an obvious risk factor for anal HPV infection.
41. Piketty C, Darragh TM, Heard I, et al. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex Transm Dis 2004; 31:96-99. This study suggests that immune reconstitution post HAART does not eradicate HPV induced anal neoplasia.
42. Saiag P, Bourgault-Vilada I, Pavlovic M, et al. Efficacy of imiquimod on external anogenital warts in HIV-infected patients previously treated by highly active antiretroviral therapy. AIDS 2002; 16:1438-1440.